Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Carvedilol and Atenolol on Anti-anginal and Metabolic Effects in Patients With Stable Angina Pectoris

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Stable angina pectoris who had a positive exercise treadmill test according to the American College of Cardiology Foundation and the American Heart Association guidelines~Exclusion Criteria:~* Acute coronary syndrome~* Coronary revascularization within the past 3 months~* Asthma or chronic obstructive lung disease~* Bradycardia (heart rate \< 55 beat/min)~* History of severe adverse reaction to beta-blockers~* Symptomatic arrhythmia requiring anti-arrhythmia therapy~* Heart failure~* Severe renal or hepatic failure

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Carvedilol (Type: EXPERIMENTAL): Carvedilol 25 mg twice a day
- Atenolol (Type: ACTIVE_COMPARATOR): Atenolol 50 mg twice a day

Based on this trial design, predict the completion outcome and termination type (if applicable).